NPPB and hydrops fetalis: Indeed, the SAVOR-TIMI 53 trial reported that diabetic individuals without known CVD but with elevated NT-proBNP levels had a 3-fold increased risk of HF development compared to counterparts with known CVD and normal NT-proBNP levels.